cause one NTF2 and one carrier must translocate through the NPC for each Ran cycle, the estimated minimal value for traffic through the pore is ϳ520 molecules NPC Ϫ1 s Ϫ1 (at 23°C).
Protein-protein interactions and calcium entry through the N-methyl-D-aspartate (NMDA)-type glutamate receptor regulate synaptic development and plasticity in the central nervous system. The EphB receptor tyrosine kinases are localized at excitatory synapses where they cluster and associate with NMDA receptors. We identified a mechanism whereby EphBs modulate NMDA receptor function. EphrinB2 activation of EphB in primary cortical neurons potentiates NMDA receptor-dependent influx of calcium. Treatment of cells with ephrinB2 led to NMDA receptor tyrosine phosphorylation through activation of the Src family of tyrosine kinases. These ephrinB2-dependent events result in enhanced NMDA receptor-dependent gene expression. Our findings indicate that ephrinB2 stimulation of EphB modulates the functional consequences of NMDA receptor activation and suggest a mechanism whereby activity-independent and activity-dependent signals converge to regulate the development and remodeling of synaptic connections.
During the development of the central nervous system, patterned neuronal activity drives the specification and maturation of synaptic connections (1, 2) . The NMDA-type excitatory glutamate receptor regulates these activity-dependent processes in part by controlling the entry of Ca 2ϩ into neurons, which then activates signaling pathways that orchestrate neuronal development (3) . Prior to the development of synapses, young neurons differentiate and begin the process of axon growth and guidance by a mechanism that is largely independent of neuronal activity (4) . The molecular mechanisms that allow activity-dependent processes to build upon activity-independent cues are not clear.
The ephrins and their receptors, the Eph tyrosine kinases, are cell-surface proteins that play a role in mediating the initial interaction between axons and dendrites as well as other activity-independent processes during neural development (5, 6) . The Eph receptor proteins are classified into the EphA and EphB families on the basis of their preference for binding of glycosyl-phosphatidylinositollinked ephrinA ligands or transmembrane ephrinB ligands, respectively. At the time of synaptogenesis, EphBs are localized to the postsynaptic region of excitatory synapses, suggesting a role for EphBs in synaptic function (7, 8) . In cultured neurons, ephrinB binding of EphB promotes the interaction of EphB with NMDA-type glutamate receptors (9) , suggesting that EphB receptor tyrosine kinases might modulate NMDA receptor function.
We investigated whether ephrinB2 activation of EphB could modulate Ca 2ϩ conductance through the NMDA receptor. To assay for changes in the concentration of intracellular Ca 2ϩ ([Ca 2ϩ ] i ), we incubated cultured cortical neurons from embryonic day 18 (E18) rats with the Ca 2ϩ indicator dye fura-2-AM (10). Although these neurons expressed NR1 and NR2B receptor subunits and responded to membrane depolarization, treatment of these neurons with glutamate (20 to 40 M) to activate the NMDA receptor in the presence of inhibitors of the L-type Ca 2ϩ channel (nimodipine) and the AMPA-type glutamate channel (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX) resulted in only a small increase in [Ca 2ϩ ] i (Fig. 1A) (11) .
This suggests that in cultured embryonic neurons, NMDA receptor subunits are expressed before synapse formation, but are not yet fully functional. We considered the possibility that ephrinB/EphBs might enhance the ability of the NMDA receptor to regulate the influx of Ca 2ϩ . Cultured cortical neurons were exposed to activated ephrinB2-Fc, a fusion protein consisting of the extracellular domain of ephrinB2 fused to the Fc portion of human immunoglobulin G1 that is multimerized with antibodies to cluster and activate EphB. Neurons were assessed for changes in [Ca 2ϩ ] i in response to glutamate stimulation. EphrinB2 treatment followed by glutamate stimulation resulted in a large increase in [Ca 2ϩ ] i (Fig. 1, A (Fig. 1B) (11) . EphrinB binding activates the EphB receptor tyrosine kinase and promotes its association with cytoplasmic proteins that mediate the effects of receptor activation (12) . We thus investigated whether the cytoplasmic domain of EphB2, including the tyrosine kinase domain, is required for the ephrinB2 potentiation of NMDA receptor-dependent Ca 2ϩ influx (10) . In neurons transfected with either vector control ( pCDNA3) or an EphB2 wild-type construct (EphB2WT), glutamate-stimulated NMDA receptor-mediated Ca 2ϩ influx was increased after ephrinB2 treatment (Fig. 1, D and E) . However, in neurons expressing an EphB2 construct containing a deletion of the EphB2 cytoplasmic domain (EphB2TR) (9), ephrinB2 treatment did not cause an increase in glutamate stimulation of NMDA receptor-dependent Ca 2ϩ influx (Fig.  1 , D and E). Thus, the cytoplasmic region of EphB2 is required for the increase in glutamatestimulated Ca 2ϩ influx through the NMDA receptor.
Tyrosine phosphorylation of the modulatory NR2 subunits of the NMDA receptor occurs both during development as well as in paradigms of synaptic plasticity, and can regulate NMDA receptor channel properties (13) (14) (15) (16) (17) . In our cortical culture system, NR2B is the predominant NR2 subunit expressed (18, 19) . To examine NR2B tyrosine phosphorylation, we stimulated cultured cortical neurons with aggregated ephrinB2-Fc or Fc, immunoprecipitated NR2B from neuronal lysates with antibodies to NR2B(anti-NR2B),andmonitoredtyrosinephosphorylation of the immunoprecipitated protein using anti-phosphotyrosine, PY99 (20) . EphrinB2 treatment of neurons increased tyrosine phosphorylation of NR2B ( Fig. 2A) . When we expressed an expression construct for NR2B with either a wild-type EphB2 construct (WT) or an EphB2 mutant that lacks kinase activity (VM and KR) in human embryonic kidney (HEK) 293T cells, we found that NR2B became tyrosine phosphorylated only when coexpressed with EphB2WT (Fig. 2B) , suggesting that EphB2 kinase activity or a kinase that associates with activated EphB is important for the ephrinB2-stimulated increase in NR2B tyrosine phosphorylation.
We also transfected into HEK293T cells an expression vector encoding EphB2 along with a vector encoding wild-type NR2B, or NR2B mutants in which tyrosines in the terminal 400 amino acids of the cytoplasmic tail of NR2B were converted to phenylalanines (20) . This mutational analysis and the subsequent generation of phospho-specific antibodies to putative sites of tyrosine phosphorylation revealed that when EphB2 and NR2B are expressed together, NR2B becomes tyrosine phosphorylated on tyrosines 1252, 1336, and 1472 (Fig. 2C) . To determine whether phosphorylation of NR2B at 1252, 1336, and 1472 by EphB2 affects Ca 2ϩ flux through the NMDA receptor, we expressed NR1 together with NR2BWT or NR2B mutated at tyrosines 1252, 1336, and 1472 (NR2BTM) 2D) . These results suggest that phosphorylation of NR2B at tyrosines 1252, 1336, and 1472 is required for the EphB2-mediated enhancement of Ca 2ϩ influx through the NMDA receptor. These three tyrosines on NR2B are phosphorylated by Fyn, a member of the Src family of tyrosine kinases (21) . Members of the Src family physically associate with both EphB and NMDA receptors, and Src family members can modulate the open time of the NMDA receptor channel (13, 17, 22, 23) (20, 24) . EphrinB2 treatment of neurons led to an increase in the amount of Src that was phosphorylated at Tyr 416 (Fig. 3A) , and to an inducible interaction between EphB2 and Src (19) . Although BDNF treatment also activates Src, BDNF does not alter glutamate-stimulated Ca 2ϩ influx and, in contrast to ephrinB2, leads to NR2B tyrosine phosphorylation at sites other than 1252, 1336, and 1472 (Fig.  1B) (19, 25, 26) . These findings suggest that ephrinB2 treatment leads to the selective localization and activation of Src and to NR2B tyrosine phosphorylation.
We used two small molecule inhibitors of the Src family of tyrosine kinases, PP2 and SU6656, to assess the importance of Src activation for ephrinB2-induced NR2B phosphorylation. Both PP2 and SU6656, but not PP3, the inactive analog of PP2, inhibited the ephrinB2-induced increase in NR2B tyrosine phosphorylation in neurons (Fig. 3B) . Also, expression of EphB2 and NR2B in HEK293T cells with a dominant inhibitory Fyn construct (FynDN), which inhibits activation of Fyn and other Src family members, inhibited NR2B tyrosine phosphorylation (19) . These findings suggest that ephrinB2 binding to EphB leads to the activation of a Src family member that in turn phosphorylates NR2B. An EphB2 mutant (EphB2-EE) that is catalytically active but cannot bind Src family members (27) did not promote tyrosine phosphorylation of NR2B (Fig. 3C) . Thus, EphB activation of Src family members is required for the effects of ephrinB2 on tyrosine phosphorylation of the NMDA receptor.
We used dominant inhibitory and constitutively active Fyn constructs (FynDN or FynCA, respectively), EphB2EE, or the Src inhibitor PP2 to determine whether Src family members are required for ephrinB-dependent potentiation of Ca 2ϩ influx through the NMDA receptor. Overexpressing FynDN, EphB2EE, or treatment with PP2 prevented the ephrinB2-induced increase in NMDA receptor-dependent [Ca 2ϩ ] i (Figs. 2D and 3, D and E) . These findings ] i in HEK293T cells expressing NR1 together with NR2BWT, or NR2BTM, and either EphB2WT, EphB2VM, or EphB2EE stimulated with 0.04 M glutamate [*P Ͻ 0.01; untreated (UT), n ϭ 30; NR1/NR2B, n ϭ 16; B2WT/NR1/NR2B, n ϭ 73; B2WT/NR1/NR2BTM, n ϭ 55; B2VM/NR1/NR2B, n ϭ 59; B2EE/NR1/NR2B, n ϭ 20). The expression levels of EphB2, NR1, and NR2B were verified by Western blot. Untransfected (non-GFP-labeled) cells did not respond to glutamate.
suggest that ephrinB2 potentiates glutamate stimulation of Ca 2ϩ influx through the NMDA receptor by inducing a Src family member, which in turn phosphorylates NR2B. The phosphorylation of NR2B then enhances the ability of the NMDA receptor to regulate the influx of Ca 2ϩ in response to glutamate. One function of ephrinB2 potentiation of glutamate-stimulated Ca 2ϩ influx might be the activation of Ca 2ϩ -regulated immediateearly genes (IEGs) (3, 28, 29) . NMDA receptor stimulation can induce IEG transcription by activating the Ca 2ϩ /cAMP-responsive element binding protein (CREB) through phosphorylation of CREB Ser 133 (3, 30) . Therefore, we assessed whether exposure of neurons to ephrinB2 affected glutamate stimulation of CREB Ser 133 phosphorylation and CREB-dependent reporter-gene transcription.
Treatment of cells with ephrinB2-Fc or glutamate alone had little effect on the level of CREB Ser 133 phosphorylation or CREBdependent reporter-gene expression (Fig. 4,  A and B) (31) . Treatment of neurons with ephrinB2-Fc, followed by glutamate stimulation, substantially increased CREB Ser 133 phosphorylation and reporter-gene transcription (Fig. 4, A and B) . The effect of ephrinB2 is mediated by the NMDA receptor because treatment of neurons with D-APV blocked the effect of ephrinB2 (Fig. 4, A and B) . EphB2TR, which blocks EphB signaling, or inhibition of Src family members with PP2 eliminated ephrinB2 potentiation of glutamate-stimulated gene expression (Fig. 4, C  and D ). These findings demonstrate that ephrinB2 potentiates CREB phosphorylation and activation by an EphB-and Src family-dependent mechanism. We next investigated whether ephrinB2 potentiates glutamate stimulation of specific IEGs that might regulate synapse formation, maturation, or function. Neurons were treated with ephrinB2 or control reagents for 45 min, then stimulated with glutamate or by membrane depolarization with elevated concentrations of KCl to stimulate the influx of Ca 2ϩ through L-type voltage-sensitive Ca 2ϩ channels (31) . Glutamate-stimulated expression of c-fos, a transcription factor that mediates cellular responses to extracellular stimuli, was enhanced after activation of EphB (Fig. 5, A and B) . The effect of ephrinB2 treatment on c-fos transcription is specific to NMDA receptor activation because the enhancement of c-fos expression was blocked by D-APV and the induction of c-fos expression by KCl stimulation was not affected by EphB activation (11) . Treatment of neurons with ephrinB2 also potentiated glutamate activation of two other genes, BDNF and cpg15, that have been implicated in synapse development and/or function (Fig. 5, C and D) (32, 33) .
Our findings suggest a model in which activity-independent cues may influence activitydependent processes by potentiating or modulating gene expression during the specification, strengthening, and remodeling of synaptic connections. This model is supported by recent experiments with EphB2-deficient mice that show an in vivo role for EphB2 in activitydependent plasticity (34, 35) . As neurons mature and form functional contacts, the effect of glutamate on Ca 2ϩ -dependent gene expression is tightly controlled. EphrinB activation of EphB promotes the clustering of NMDA receptors, and the modulation of NMDA receptor by EphB may sensitize the neurons to the effects of glutamate. Glutamate then stimulates increased Ca 2ϩ influx to trigger programs of gene expression that may affect synapse formation, maturation, and plasticity. Taken together, these observations suggest that the ephrinB-EphB-NMDA receptor interaction may represent an early step in the initiation of synapse formation or maturation and may potentiate the ability of the NMDA receptor to respond to activitydependent signals from the extracellular milieu. 
